image for site
Research
Login
arrow
Artera Logo

Artera

check

An AI-driven platform for the personalized treatment of localized prostate cancer.

HQ

Los Altos, CA USA

N/A

N/A

Founded
2020
Company
Analysis
Valuation
Contacts
Artera is a computational pathology platform that develops tools to support personalized clinical care for cancer treatment. The company's platform utilizes a multimodal AI test to personalize therapy and optimize treatment decision-making between clinicians and patients.
Artera was founded in 2020 by Jonathan Wong.
Employees
16
As of Mar 23, 2023
Total Raised to Date
$90,000,000
6 Months Since Last Deal
Last Deal Details
$90,000,000
Seed (March, 2023)
Last Valuation
Undisclosed

Company Overview

Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Healthcare, Data & Analytics
Technology
AI / ML, Data Visualization
Tags
HealthTech, CPATH

Operating Model

Model Type(s)
Subscription, Professional Services
Revenue Type(s)
Recurring, Transactional
Customer Type(s)
Government, Enterprise
Geographic Exposure
USA
Total Customers
25 - 100
Retention Range
90 - 95%

Artera - FAQ

When was Artera founded?
Arterawas founded in 2020.
Where is Artera’s headquarters located?
Artera’sheadquarters is located in Los Altos, CA, USA.
How many employees does Artera have?
Arterahas 16 employees as of March 23, 2023.
How much has Artera raised to-date?
As of September 18, 2023,Arterahas raised a total of $90.00 million (USD) since 2020.
When was Artera’s last funding round?
Artera’smost recent funding round was for $90.00 million (USD) in March 2023.
How many customers does Artera have?
Arterahas an estimated 25 - 100 customers as of April 22, 2023.
Who are Artera competitors?
Companies similar toArteraincludePathAI,Paige, andPathologyWatch.
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts
image for siteimage for site